Kite Pharma Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT) products for the treatment of cancer, and GE Global Research, the centralized research and development hub for GE, have formed a strategic research collaboration to develop a next-generation, functionally integrated and automated manufacturing system for engineered T cell therapy. Kite and GE Global Research aim to change the paradigm of engineered T cell therapy manu...